This study investigates advanced solid tumors. It involves individuals who have not responded to existing treatments for their condition.
The study evaluates the investigational medication's safety and effectiveness in individuals with advanced solid tumors.
- Who can participate: Adults 18 years and older with advanced solid tumors that have not responded to standard treatments may participate. Participants must have measurable lesions and good organ function.
- Study details: Participants will receive the investigational medication.